Invention Grant
- Patent Title: Use of levocetirizine and montelukast in the treatment of vasculitis
-
Application No.: US15584499Application Date: 2017-05-02
-
Publication No.: US10206919B2Publication Date: 2019-02-19
- Inventor: Bruce Chandler May
- Applicant: INFLAMMATORY RESPONSE RESEARCH, INC.
- Applicant Address: US CA Santa Barbara
- Assignee: IRR, Inc.
- Current Assignee: IRR, Inc.
- Current Assignee Address: US CA Santa Barbara
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Main IPC: A61K31/495
- IPC: A61K31/495 ; A61K31/136 ; A61K31/454 ; A61K31/47 ; A61K31/496 ; A61K31/519 ; A61K31/56 ; A61K31/573 ; A61K39/395 ; A61K45/06
Abstract:
The embodiments described herein include methods and formulations for treating vasculitis. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
Public/Granted literature
- US20170231980A1 USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF VASCULITIS Public/Granted day:2017-08-17
Information query
